These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 5063865)
21. The electrophysiologic effects of antiarrhythmic drugs. Gettes LS Am J Cardiol; 1971 Nov; 28(5):526-35. PubMed ID: 4398978 [No Abstract] [Full Text] [Related]
22. Clinical value of the electrogram of the conduction system. Damato AN; Lau SH Prog Cardiovasc Dis; 1970 Sep; 13(2):119-40. PubMed ID: 4919601 [No Abstract] [Full Text] [Related]
24. Antiarrhythmic drugs: electrophysiological and pharmacokinetic considerations. Sasyniuk BI; Ogilvie RI Annu Rev Pharmacol; 1975; 15():131-55. PubMed ID: 1096787 [No Abstract] [Full Text] [Related]
25. Observations on the effects of selected antiarrhythmic drugs on mammalian cardiac purkinje fibers with two levels of steady-state potential: influences of lidocaine, phenytoin, propranolol, disopyramide and procainamide on repolarization, action potential shape and conduction. Arnsdorf MF; Mehlman DJ J Pharmacol Exp Ther; 1978 Dec; 207(3):983-91. PubMed ID: 731444 [No Abstract] [Full Text] [Related]
26. [Comparative study of the effect of some drugs on A-V conduction by recording of the His electrocardiogram]. Freni F; Buttafarro A; Pavia L; Siracusano L; Gugliandolo A; Casella G Boll Soc Ital Cardiol; 1978; 23(2):322-6. PubMed ID: 754787 [No Abstract] [Full Text] [Related]
27. [Mode of action of antiarrhythmic drugs (author's transl)]. Sano T Kokyu To Junkan; 1974 Apr; 22(4):321-6. PubMed ID: 4603686 [No Abstract] [Full Text] [Related]
28. Rational basis of antiarrhythmic therapy: clinical pharmacology of commonly used antiarrhythmic drugs. Singh BN Angiology; 1978 Mar; 29(3):206-42. PubMed ID: 347988 [No Abstract] [Full Text] [Related]
29. The nervous system as a site of action for digitalis and antiarrhythmic drugs. Levitt B; Raines A; Sohn YJ; Standaert FG; Hirshfeld JW Mt Sinai J Med; 1970; 37(3):227-40. PubMed ID: 4911079 [No Abstract] [Full Text] [Related]
30. The comparative inotropic effects of six clinically used antiarrhythmic agents. Hammermeister KE; Boerth RC; Warbasse JR Am Heart J; 1972 Nov; 84(5):643-52. PubMed ID: 4639738 [No Abstract] [Full Text] [Related]
31. The interaction of d-tubocurarine with antiarrhythmic drugs. Harrah MD; Way WL; Katzung BG Anesthesiology; 1970 Oct; 33(4):406-10. PubMed ID: 5512329 [No Abstract] [Full Text] [Related]
32. Inhibition of incorporation of leucine into myocardial proteins of the rat by antiarrhythmic agents. Beller BM; Mongillo S Circ Res; 1969 Oct; 25(4):401-6. PubMed ID: 5347221 [No Abstract] [Full Text] [Related]
33. Cardiovascular effects of equi-antiarrhythmic doses of alprenolol (a beta-adrenergic receptor antagonist) diphenylhydantoin and procainamide. Proctor JD; Allen FJ; Wasserman AJ Arch Int Pharmacodyn Ther; 1971 Apr; 190(2):354-67. PubMed ID: 4396926 [No Abstract] [Full Text] [Related]
34. Review: Electrolyte and antiarrhythmic drug interaction. Dreifus LS; de Azevedo IM; Watanabe Y Am Heart J; 1974 Jul; 88(1):95-107. PubMed ID: 4152041 [No Abstract] [Full Text] [Related]
38. A comparison of the cardiac activity of a new antiarrhythmic drug--pipazetate--with quinidine, procainamide, antazoline and diphenylhydantoin. Giuliano H Arch Int Pharmacodyn Ther; 1970 Nov; 188(1):189-99. PubMed ID: 4394965 [No Abstract] [Full Text] [Related]